Yuwang Pharmaceutical CPHI 2025: Showcasing the Hard Power of China’s API Industry
2025.06.30

June 26th
The 23rd World Pharmaceutical Raw Materials China Exhibition
CPHI China 2025

      
Successfully concluded at the Shanghai New International Expo Center
As a benchmark enterprise in the field of pharmaceutical raw materials in China, Yuwang Pharmaceutical showcased its full range of high-quality refined fish oil and soft/hard capsule/tablet products, showcasing its full industry chain strength from raw material research and development to terminal applications to global customers.
exhibition scene
During the exhibition, Yuwang Pharmaceutical’s booth attracted professional visitors from Europe, America, Southeast Asia and other regions to stop and exchange ideas.


The company’s professional sales team conducted in-depth technical discussions with visiting customers on product processes, quality standards, etc., and reached multiple cooperation intentions on site.


As a manufacturer of functional fish oil and dietary supplements in the entire industry chain, the company has an annual processing capacity of 20000 tons of fish oil and a global sales network covering more than 80 countries. It has passed multiple international certifications such as ISO22000 food safety system certification, ISO9001 quality management system certification, ISO45001 occupational health and safety management system certification, and BRC global food safety standard system certification for its quality management system.
Although the exhibition has come to an end, cooperation never stops. Yuwang Pharmaceutical will continue to deepen its dual wheel drive strategy of “technology+internationalization”, providing better pharmaceutical raw material solutions for global partners with more than 30 years of professional accumulation, and jointly promoting the development of the pharmaceutical and health industry.

Share: